Press releases – Targovax

January 17, 2022

Press release - Non-regulatory

Targovax granted Patents for ONCOS-102 in combination with chemotherapy in China and Japan

IR contact

Renate Birkeli

Investor Relations

+47 922 61 624

Targovax ASA announced its third quarter 2021 results on Thursday November 4, 2021. An online presentation by Targovax’s management to investors, analysts and the press will take place at 10:00 am CET.

Report
Presentation
Webcast

Read the report

This website uses cookies to ensure you get the best experience on our website. Learn More | Terms of Use

Yes, I accept

Targovax granted Patents for ONCOS-102 in combination with chemotherapy in China and Japan

Subscribe